Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
J Biol Chem ; 276(20): 17301-6, 2001 May 18.
Article in English | MEDLINE | ID: mdl-11278679

ABSTRACT

Cognitive impairment is a major feature of Alzheimer's disease and is accompanied by beta-amyloid (Abeta) deposition. Transgenic animal models that overexpress Abeta exhibit learning and memory impairments, but neuronal degeneration is not a consistent characteristic. We report that levels of Abeta-(1-42), which do not compromise the survival of cortical neurons, may indeed interfere with functions critical for neuronal plasticity. Pretreatment with Abeta-(1-42), at sublethal concentrations, resulted in a suppression of cAMP-response element-binding protein (CREB) phosphorylation, induced by exposure to either 30 mm KCl or 10 microm N-methyl-d-aspartate. The effects of Abeta-(1-42) seem to involve mechanisms unrelated to degenerative changes, since Abeta-(25-35), a toxic fragment of Abeta, at sublethal concentrations did not interfere with activity-dependent CREB phosphorylation. Furthermore, caspase inhibitors failed to counteract the Abeta-(1-42)-evoked suppression of CREB activation. Abeta-(1-42) also interfered with events downstream of activated CREB. The Abeta-(1-42) treatment suppressed the activation of the cAMP response element-containing brain-derived neurotrophic factor (BDNF) exon III promoter and the expression of BDNF exon IIII mRNA induced by neuronal depolarization. In view of the critical role of CREB and BDNF in neuronal plasticity, including learning and memory, the observations indicate a novel pathway through which Abeta may interfere with neuronal functions and contribute to cognitive deficit in Alzheimer's disease before the stage of massive neuronal degeneration.


Subject(s)
Amyloid beta-Peptides/pharmacology , Brain-Derived Neurotrophic Factor/genetics , Cyclic AMP Response Element-Binding Protein/metabolism , Neurons/physiology , Peptide Fragments/pharmacology , Signal Transduction/physiology , Transcription, Genetic/physiology , Amino Acid Chloromethyl Ketones/pharmacology , Animals , Cell Survival/drug effects , Cells, Cultured , Cerebral Cortex/cytology , Cerebral Cortex/physiology , Cyclic AMP Response Element-Binding Protein/drug effects , Cysteine Proteinase Inhibitors/pharmacology , Embryo, Mammalian , Exons , Gene Expression Regulation/drug effects , N-Methylaspartate/pharmacology , Neurons/cytology , Neurons/drug effects , Phosphorylation , Potassium Chloride/pharmacology , Promoter Regions, Genetic , RNA, Messenger/genetics , Rats , Signal Transduction/drug effects , Transcription, Genetic/drug effects
2.
J Gerontol A Biol Sci Med Sci ; 55(2): B106-12, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10737685

ABSTRACT

The age-related decline in growth hormone is one of the most robust endocrine markers of biological aging and has been hypothesized to contribute to the physiological deficits observed in aged animals. However, there have been few studies of the impact of this hormonal decline on brain aging. In this study, the effect of long-term subcutaneous administration of [D-Ala2]-growth hormone-releasing hormone (GHRH) on one measure of brain function, memory, was investigated. Animals were injected daily with 2.3 microg of [D-Ala2]-GHRH or saline from 9 to 30 months of age, and the spatial learning and reference memory of animals were assessed by using the Morris water maze and compared with those of 6-month-old animals. Results indicated that spatial memory decreased with age and that chronic [D-Ala2]-GHRH prevented this age-related decrement (24% improvement in the annulus-40 time and 23% improvement in the number of platform crossings compared with saline treated, age-matched controls; p < .05 each). No changes were noted in sensorimotor performance. [D-Ala2]-GHRH attenuated the age-related decline in plasma concentrations of insulinlike growth factor-1 (IGF-1) (p <.05). These data suggest that growth hormone and IGF-1 have important effects on brain function, that the decline in growth hormone and IGF-1 with age contributes to impairments in reference memory, and that these changes can be reversed by the chronic administration of GHRH.


Subject(s)
Aging , Growth Hormone-Releasing Hormone/therapeutic use , Memory Disorders/prevention & control , Space Perception/drug effects , Spatial Behavior/drug effects , Animals , Brain/drug effects , Case-Control Studies , Growth Hormone/blood , Growth Hormone-Releasing Hormone/administration & dosage , Injections, Subcutaneous , Insulin-Like Growth Factor I/analysis , Learning , Male , Psychomotor Performance/drug effects , Rats , Rats, Inbred BN , Rats, Inbred F344 , Sodium Chloride , Swimming , Time Factors
3.
Brain Res Bull ; 51(4): 331-8, 2000 Mar 01.
Article in English | MEDLINE | ID: mdl-10704784

ABSTRACT

N-Methyl-D-aspartate (NMDA) receptors have been reported to have an important role in synaptic plasticity and neurodegeneration. Two major subtypes of these receptors, NMDAR1 and NMDAR2, are present in brain and heterogeneity of these receptors have been reported to define specific functional responses. In this study, the effects of age and chronic insulin-like growth factor-1 (IGF-1) administration on NMDA receptor density and subtype expression were investigated in frontal cortex, CA1, CA2/3 and the dentate gyrus of the hippocampus of young (10 months), middle-aged (21 months) and old (30 months) male Fisher 344xBrown Norway (F1) rats. No age-related changes in (125)I-MK-801 binding or NMDAR1 protein expression were observed in hippocampus or frontal cortex. However, analysis of NMDAR2A and NMDAR2B protein expression in hippocampus indicated a significant decrease between 21 and 30 months of age and administration of IGF-1 increased these receptor subtypes. In cortex, NMDAR2A and NMDAR2B protein expression were not influenced by age or IGF-1 treatment, although NMDAR2C protein expression decreased with age and this decline was not ameliorated by IGF-1 administration. These data demonstrate that NMDA receptor subtypes are altered with age in a regional and subtype specific manner. We conclude that both age and IGF-1 regulate the expression of NMDA receptor subtypes and suggest that age-related changes in NMDA receptor heterogeneity may result in functional changes in the receptor that have relevance for aging.


Subject(s)
Aging/metabolism , Cerebral Cortex/metabolism , Hippocampus/metabolism , Insulin-Like Growth Factor I/pharmacology , Receptors, N-Methyl-D-Aspartate/metabolism , Animals , In Vitro Techniques , Injections, Intraventricular , Insulin-Like Growth Factor I/metabolism , Male , Radioimmunoassay , Radioligand Assay , Rats
4.
Article in English | MEDLINE | ID: mdl-11191712

ABSTRACT

1. Normal aging is thought to proceed through two stages: initiation and propagation. Each of these phases is associated with different neuroanatomical events, vulnerabilities to injury and responsiveness to interventions. 2. The role of beta-amyloid (Abeta) in neuron dysfunction in the initiation stage may be mediated through alterations in signal transduction pathways involving cyclic AMP response element binding protein (CREB). CREB phosphorylation is associated with the expression of brain derived neurotrophic factor (BDNF), which promotes neuron health and survival. In primary neuronal cultures, Abeta decreases the phosphorylation of CREB, which results in up to a 31% decrease in BDNF levels. 3. In vivo studies also support a role for Abeta in neuron dysfunction since soluble Abeta levels correlate with the loss of synapses in brains of non-demented humans with high pathology. 4. The authors hypothesize that interventions during the initiation stage, when neuron dysfunction, but not overt pathology, is present, have the most promise to promote successful aging. The dog can serve as a useful model for interventions during the initiation stage since dogs develop neuropathology that closely resembles that observed in high pathology human brains.


Subject(s)
Aging/pathology , Amyloid beta-Peptides/pharmacology , Brain/pathology , Amyloid beta-Peptides/metabolism , Animals , Cyclic AMP/metabolism , Disease Models, Animal , Dogs , Humans , Neurons/pathology , Signal Transduction
5.
Neurobiol Dis ; 6(5): 440-9, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10527810

ABSTRACT

The Alzheimer disease-associated beta-amyloid peptide has been shown to induce apoptotic neuronal death. In the present study, we test the hypothesis that the apoptotic pathway activated by beta-amyloid is similar to the pathway activated by the Fas/TNFR family of death receptors, which requires caspase-8 activity and adaptor proteins such as FADD. We demonstrate that the selective caspase-8 inhibitor IETD-fmk blocks neuronal death induced by beta-amyloid. Furthermore, using viral-mediated gene delivery, we show that neurons expressing dominant-negative FADD are protected from apoptosis induced by beta-amyloid. Together these results indicate that the apoptotic pathway activated by beta-amyloid requires both caspase-8 activity and FADD. These findings further support the hypothesis that beta-amyloid might initiate apoptosis by cross-linking death receptors of the Fas/TNFR family.


Subject(s)
Adaptor Proteins, Signal Transducing , Amyloid beta-Peptides/toxicity , Apoptosis/physiology , Caspases/metabolism , Neurons/cytology , Neurons/physiology , Peptide Fragments/toxicity , Animals , Apoptosis/drug effects , Carrier Proteins/metabolism , Caspase 8 , Caspase 9 , Caspase Inhibitors , Cell Death/drug effects , Cells, Cultured , Embryo, Mammalian , Enzyme Inhibitors/pharmacology , Fas-Associated Death Domain Protein , Hippocampus/cytology , Hippocampus/physiology , Humans , Models, Neurological , Neurons/drug effects , Rats , Signal Transduction , Staurosporine/pharmacology
6.
Neurobiol Aging ; 20(2): 191-200, 1999.
Article in English | MEDLINE | ID: mdl-10537028

ABSTRACT

The present study was designed to assess the impact of moderate caloric restriction (60% of ad libitum fed animals) on cerebral vascular density and local cerebral blood flow. Vascular density was assessed in male Brown-Norway rats from 7-35 months of age using a cranial window technique. Arteriolar density, arteriole-arteriole anastomoses, and venular density decreased with age and these effects were attenuated by moderate caloric restriction. Analysis of local cerebral blood using [14C]iodoantipyrine indicated that basal blood flow decreased with age in CA1, CA3 and dentate gyrus of hippocampus; similar trends were evident in cingulate, retrosplenal, and motor cortex. Basal blood flow was increased in all brain regions of moderate caloric restricted old animals (compared to old ad libitum fed animals) and no differences were observed between ad libitum fed young and caloric restricted older animals. In response to a CO2 challenge to maximally dilate vessels, blood flow increased in young and old ad libitum fed animals, but a similar increase was not observed in caloric restricted old animals. We conclude that a decrease in cerebral vasculature is an important contributing factor in the reduction in blood flow with age. Nevertheless, vessels from young and old animals have the capacity to dilate in response to a CO2 challenge and, after CO2, no differences are observed between the two age-groups. These results are consistent with the hypothesis that aged animals fail to adequately regulate local cerebral blood flow in response to physiological stimuli. Moderate caloric restriction increases microvascular density and cerebral blood flow in aged animals but tissues exhibit little or no increase in blood flow in response to CO2 challenge. The cause of this deficient response may indicate that vessels are maximally dilated in aged calorically restricted animals or that they fail to exhibit normal regulatory control.


Subject(s)
Aging/physiology , Cerebral Cortex/blood supply , Cerebrovascular Circulation/physiology , Energy Intake/physiology , Microcirculation/physiology , Animals , Autoradiography , Carbon Dioxide/pharmacology , Cerebral Cortex/physiology , Cerebrovascular Circulation/drug effects , Gyrus Cinguli/blood supply , Gyrus Cinguli/physiology , Hippocampus/blood supply , Hippocampus/physiology , Male , Microcirculation/drug effects , Motor Cortex/blood supply , Motor Cortex/physiology , Rats , Rats, Inbred BN
7.
Neuroscience ; 88(1): 269-79, 1999 Jan.
Article in English | MEDLINE | ID: mdl-10051206

ABSTRACT

Ageing in mammals is characterized by a decline in plasma levels of insulin-like growth factor-1 that appears to contribute to both structural and functional changes in a number of tissues. Although insulin-like growth factor-1 has been shown to provide trophic support for neurons and administration of insulin-like growth factor-1 to ageing animals reverses some aspects of brain ageing, age-related changes in insulin-like growth factor-1 or type 1 insulin-like growth factor receptors in brain have not been well documented. In this series of studies, insulin-like growth factor-1 messenger RNA and protein concentrations, and type 1 insulin-like growth factor receptor levels were analysed in young (three to four- and 10-12-month-old), middle-aged (19-20-month-old) and old (29-32-month-old) Fisher 344 x Brown Norway rats. Localization of insulin-like growth factor-1 messenger RNA throughout the lifespan revealed that expression was greatest in arteries, arterioles, and arteriolar anastomoses with greater than 80% of these vessels producing insulin-like growth factor-1 messenger RNA. High levels of expression were also noted in the meninges. No age-related changes were detected by either in situ hybridization or quantitative dot blot analysis of cortical tissue. However, analysis of insulin-like growth factor-1 protein levels in cortex analysed after saline perfusion indicated a 36.5% decrease between 11 and 32 months-of-age (P<0.05). Similarly, analysis of type 1 insulin-like growth factor receptor messenger RNA revealed no changes with age but levels of type 1 insulin-like growth factor receptors indicated a substantial decrease with age (31% in hippocampus and 20.8 and 27.3% in cortical layers II/III and V/VI, respectively). Our results indicate that (i) vasculature and meninges are an important source of insulin-like growth factor-1 for the brain and that expression continues throughout life, (ii) there are no changes in insulin-like growth factor-1 gene expression with age but insulin-like growth factor-1 protein levels decrease suggesting that translational deficiencies or deficits in the transport of insulin-like growth factor-1 through the blood-brain barrier contribute to the decline in brain insulin-like growth factor-1 with age, and (iii) type 1 insulin-like growth factor receptor messenger RNA is unchanged with age but type 1 insulin-like growth factor receptors decrease in several brain regions. We conclude that significant perturbations occur in the insulin-like growth factor-1 axis with age. Since other studies suggest that i.c.v. administration of insulin-like growth factor-1 reverses functional and cognitive deficiencies with age, alterations within the insulin-like growth factor-1 axis may be an important contributing factor in brain ageing.


Subject(s)
Aging/metabolism , Arterioles/metabolism , Brain/blood supply , Gene Expression Regulation , Insulin-Like Growth Factor I/genetics , Receptor, IGF Type 1/genetics , Animals , Arterioles/growth & development , Brain/growth & development , Brain/metabolism , Cerebral Cortex/blood supply , Cerebrovascular Circulation , Hippocampus/metabolism , Insulin-Like Growth Factor I/metabolism , Male , Microcirculation/growth & development , Microcirculation/metabolism , Protein Biosynthesis , RNA, Messenger/analysis , RNA, Messenger/genetics , Rats , Rats, Inbred BN , Rats, Inbred F344 , Receptor, IGF Type 1/metabolism , Transcription, Genetic
8.
J Gerontol A Biol Sci Med Sci ; 54(12): B521-38, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10647962

ABSTRACT

Moderate caloric restriction (60% of ad libitum intake) is an important model to investigate potential mechanisms of biological aging. This regimen has been reported to decrease the number of pathologies and increase life span in all species tested to date. Although moderate caloric restriction induces a wide range of physiological changes within the organism, adaptive changes within the endocrine system are evident and serve to maintain blood levels of glucose. These alterations include an increase in growth hormone secretory dynamics and a decline in plasma levels of IGF-1. These endocrine compensatory mechanisms can be induced at any age, and we have proposed that these alterations mediate some of the beneficial aspects of moderate caloric restriction. Numerous studies indicate that growth hormone and IGF-1 decrease with age and that administration of these hormones ameliorates the deterioration of tissue function evident in aged ad libitum-fed animals, suggesting that the absence of these hormones contributes to the phenotype of aging. Nevertheless, IGF-1 is an important risk factor in age-related pathologies including lung, breast, and prostate cancer. From these studies, we propose that endocrine compensatory mechanisms induced by moderate caloric restriction (including increased growth hormone and decreased IGF-1) decrease the stimulus for cellular replication, resulting in a decline in pathologies and increased life span observed in these animals. These findings have important implications for potential mechanisms of moderate caloric restriction and suggest that neuroendocrine compensatory mechanisms exert a key role on the actions of moderate caloric restriction on life span.


Subject(s)
Aging/physiology , Energy Intake , Growth Hormone/physiology , Insulin-Like Growth Factor I/physiology , Animals , Blood Glucose/analysis , Cell Division/physiology , Disease Models, Animal , Female , Growth Hormone/metabolism , Insulin-Like Growth Factor I/analysis , Longevity , Lung Neoplasms/etiology , Male , Mammary Neoplasms, Experimental/etiology , Neurosecretory Systems/physiology , Phenotype , Prostatic Neoplasms/etiology , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...